Nobel Prize in Medicine 2026 Goes to Three Scientists for Breakthroughs in Optogenetics

The 2026 Nobel Prize in Physiology or Medicine has been jointly awarded to scientists Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries that helped establish optogenetics, a technology that allows researchers to control nerve cells using light. The Nobel committee announced the award on Monday, recognising the three scientists for their work on light-gated ion channels. Their discoveries have transformed neuroscience by giving researchers a way to study the activity of individual neurons with a level of precision that was previously difficult to achieve.

Hegemann and Nagel played a crucial role in identifying and characterising proteins that respond to light. Their research focused on channelrhodopsins, light-sensitive proteins found in microorganisms such as green algae. When exposed to light, these proteins can allow charged particles to pass through cell membranes, effectively changing the electrical activity of a cell.

Deisseroth later helped turn these findings into a practical tool for neuroscience. His research demonstrated how genes responsible for light-sensitive proteins could be introduced into nerve cells, allowing those cells to be activated or inhibited using pulses of light.

The technique became known as optogenetics and opened new possibilities for studying the brain. By targeting particular groups of neurons, scientists can observe how specific cells and neural circuits contribute to functions such as movement, memory, emotions and behaviour.

The technology has proved particularly valuable because traditional methods of manipulating brain activity often affect large groups of cells. Optogenetics, by contrast, can provide much greater control over selected neurons, enabling researchers to investigate the relationship between individual neural circuits and complex behaviours. The Nobel committee said the discoveries made by the three laureates have fundamentally changed the ability of researchers to investigate the nervous system. The technique has subsequently been adopted by laboratories around the world and has become an important tool in modern neuroscience.

Beyond basic research, optogenetics is also being explored for possible medical applications. Scientists are studying whether light-based approaches could eventually help treat or understand neurological and psychiatric conditions. Research is also underway into applications involving vision, including methods that could potentially restore some visual functions.

The three laureates will share the Nobel Prize award of 12 million Swedish kronor, which is roughly equivalent to $1.2 million. The announcement marks the beginning of this year’s Nobel Prize announcements, with awards in other fields scheduled to follow.

The recognition of Deisseroth, Hegemann and Nagel highlights how discoveries initially made through the study of light-sensitive proteins in microorganisms can lead to powerful tools for understanding one of the most complex systems in nature.